论文部分内容阅读
目的:探究雾化吸入和全身糖皮质激素给药对AECOPD合并2型糖尿病患者的临床治疗效果。方法:选取我院2013年8月至2015年4月期间收治的98例患者,按照抽签法将其分为观察组以及对照组,观察组采用雾化吸入治疗,对照组采用全身糖皮质激素治疗,对比两组患者治疗后的疗效。结果:观察组患者经治疗后其治疗效果明显好于对照组,组间经对比以P<0.05为差异,具有统计学意义。结论:对AECOPD合并2型糖尿病患者进行治疗的过程中应采取雾化吸入方法,其治疗效果良好,具有临床应用价值。
Objective: To investigate the clinical effect of inhalation and systemic glucocorticoid on AECOPD patients with type 2 diabetes mellitus. Methods: A total of 98 patients admitted to our hospital from August 2013 to April 2015 were selected and divided into observation group and control group according to the drawing method. The observation group was treated with inhalation of atomization and the control group was treated with systemic glucocorticoid , Compared two groups of patients after treatment efficacy. Results: The treatment group of patients in the observation group was significantly better than the control group after treatment, the difference between groups by P <0.05 was statistically significant. Conclusion: AECOPD patients with type 2 diabetes mellitus should be treated by nebulization method, which has good therapeutic effect and clinical value.